Patients who develop chronic fibrotic liver disease, caused by viral or metabolic aetiologies,
are at a high risk of developing hepatocellular carcinoma (HCC). Even after complete HCC …

Hepatocellular carcinoma (HCC) is a highly prevalent and lethal neoplasia, the
management of which has significantly improved during the last few years. A better …

Background & Aims Gastrointestinal (GI), liver, and pancreatic diseases are a source of
substantial morbidity, mortality, and cost in the United States. Quantification and statistical …

EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

Hepatitis C virus (HCV) is an increasing cause of morbidity and mortality in the United
States. Many of the 2.7–3.9 million persons living with HCV infection are unaware they are …

Importance Current recommendations for patients with cirrhosis are to undergo surveillance
for hepatocellular carcinoma (HCC) with ultrasonography (US) every 6 months. However …

EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

Background It is well known that the incidence of developing hepatocelluler carcinoma
(HCC) is increased in liver cirrhosis of different etiologies. However, comparison of HCC …

These recommendations provide a data-supported approach to the diagnosis, staging and
treatment of patients diagnosed with hepatocellular carcinoma (HCC). They are based on …

Background & Aims Both hepatic resection and radiofrequency ablation (RFA) are
considered curative treatments for hepatocellular carcinoma (HCC), but their economic …